Skip to main content
Erschienen in: Clinical Rheumatology 5/2006

01.09.2006 | Original Article

A multicenter study of patients with adult-onset Still’s disease compared with systemic juvenile idiopathic arthritis

verfasst von: Salih Pay, Nuran Türkçapar, Mukaddes Kalyoncu, İsmail Şimşek, Esin Beyan, İhsan Ertenli, M. Akif Öztürk, Nurşen Düzgün, Hakan Erdem, Zeynep Özbalkan, Sedat Kiraz, Gülay Kınıklı, Nesrin Besbas, Ayhan Dinç, Aşkın Ateş, Ümit Ölmez, Meral Çalgüneri, Olcay Tiryaki Aydıntuğ, Ayşin Bakkaloğlu, Mustafa Turan, Murat Turgay, Yaşar Karaaslan, Rezzan Topaloğlu, Murat Duman, Seza Özen, Ankara Rheumatology Study Group

Erschienen in: Clinical Rheumatology | Ausgabe 5/2006

Einloggen, um Zugang zu erhalten

Abstract

Adult-onset Still’s disease (AOSD) has often been regarded as the adult spectrum of systemic juvenile idiopathic arthritis (sJIA). The present study aims to compare the clinical and laboratory features, the disease course and the response to treatment in patients having AOSD with those having sJIA. Retrospective review of all available data that were filled out by adult and paediatric rheumatologists from six centers using a standard data extraction form was performed. A total of 95 patients with AOSD and 25 patients with sJIA were recruited for the study. The frequency of fever, rash, myalgia, weight loss and sore throat was higher in patients with AOSD. The pattern of joint involvement differed slightly. Laboratory findings were similar in both groups, except that liver dysfunction and neutrophilia were more common among adults. A multiphasic pattern dominated the childhood cases, whereas the most frequent course was a chronic one in adults. Corticosteroids and methotrexate were the most commonly employed therapy; however, chloroquine was another popular therapy in the adult group. We showed a difference in the rate of clinical and laboratory features between patients with AOSD and those with sJIA. AOSD and sJIA may still be the same disease, and children may simply be reacting differently as the result of the first encounter of the putative antigens with the immune system.
Literatur
1.
Zurück zum Zitat Petty RE, Southwood TR, Baum J, Bhettay E, Glass DN, Manners P et al (1998) Revision of the proposed classification criteria for juvenile idiopathic arthritis: Durban, 1997. J Rheumatol 25:1991–1994PubMed Petty RE, Southwood TR, Baum J, Bhettay E, Glass DN, Manners P et al (1998) Revision of the proposed classification criteria for juvenile idiopathic arthritis: Durban, 1997. J Rheumatol 25:1991–1994PubMed
2.
Zurück zum Zitat Bywaters EG (1971) Still’s disease in the adult. Ann Rheum Dis 30:121–133PubMed Bywaters EG (1971) Still’s disease in the adult. Ann Rheum Dis 30:121–133PubMed
3.
Zurück zum Zitat Yamaguchi M, Ohta A, Tsunematsu T, Kasukawa R, Mizushima Y, Kashiwagi H et al (1992) Preliminary criteria for classification of adult Still’s disease. J Rheumatol 19:424–430PubMed Yamaguchi M, Ohta A, Tsunematsu T, Kasukawa R, Mizushima Y, Kashiwagi H et al (1992) Preliminary criteria for classification of adult Still’s disease. J Rheumatol 19:424–430PubMed
4.
Zurück zum Zitat Tanaka S, Matsumoto Y, Ohnishi H, Maeda M, Nishioka K, Kashiwazaki S et al (1991) Comparison of clinical features of childhood and adult onset Still’s disease. Ryumachi 31:511–518PubMed Tanaka S, Matsumoto Y, Ohnishi H, Maeda M, Nishioka K, Kashiwazaki S et al (1991) Comparison of clinical features of childhood and adult onset Still’s disease. Ryumachi 31:511–518PubMed
5.
Zurück zum Zitat Uppal SS, Pande IR, Kumar A, Kailash S, Sekharan NG, Adya CM et al (1995) Adult onset Still’s disease in northern India: comparison with juvenile onset Still’s disease. Br J Rheumatol 34:429–434PubMedCrossRef Uppal SS, Pande IR, Kumar A, Kailash S, Sekharan NG, Adya CM et al (1995) Adult onset Still’s disease in northern India: comparison with juvenile onset Still’s disease. Br J Rheumatol 34:429–434PubMedCrossRef
6.
Zurück zum Zitat Luthi F, Zufferey P, Hofer MF, So AK (2002) Adolescent-onset Still’s disease: characteristics and outcome in comparison with adult-onset Still’s disease. Clin Exp Rheumatol 20:427–430PubMed Luthi F, Zufferey P, Hofer MF, So AK (2002) Adolescent-onset Still’s disease: characteristics and outcome in comparison with adult-onset Still’s disease. Clin Exp Rheumatol 20:427–430PubMed
7.
Zurück zum Zitat Cabane J, Michon A, Ziza JM, Bourgeois P, Bletry O, Godeau P et al (1990) Comparison of long term evolution of adult onset and juvenile onset Still’s disease, both followed up for more than 10 years. Ann Rheum Dis 49:283–285PubMedCrossRef Cabane J, Michon A, Ziza JM, Bourgeois P, Bletry O, Godeau P et al (1990) Comparison of long term evolution of adult onset and juvenile onset Still’s disease, both followed up for more than 10 years. Ann Rheum Dis 49:283–285PubMedCrossRef
8.
Zurück zum Zitat Lin SJ, Chao HC, Yan DC (2000) Different articular outcomes of Still’s disease in Chinese children and adults. Clin Rheumatol 19:127–130CrossRefPubMed Lin SJ, Chao HC, Yan DC (2000) Different articular outcomes of Still’s disease in Chinese children and adults. Clin Rheumatol 19:127–130CrossRefPubMed
9.
Zurück zum Zitat Kawashima M, Yamamura M, Taniai M, Yamauchi H, Tanimoto T, Kurimoto M et al (2001) Levels of interleukin-18 and its binding inhibitors in the blood circulation of patients with adult-onset Still’s disease. Arthritis Rheum 44:550–560CrossRefPubMed Kawashima M, Yamamura M, Taniai M, Yamauchi H, Tanimoto T, Kurimoto M et al (2001) Levels of interleukin-18 and its binding inhibitors in the blood circulation of patients with adult-onset Still’s disease. Arthritis Rheum 44:550–560CrossRefPubMed
10.
Zurück zum Zitat Sugiura T, Kawaguchi Y, Harigai M, Terajima-Ichida H, Kitamura Y, Furuya T et al (2002) Association between adult-onset Still’s disease and interleukin-18 gene polymorphisms. Genes Immun 3:394–399CrossRefPubMed Sugiura T, Kawaguchi Y, Harigai M, Terajima-Ichida H, Kitamura Y, Furuya T et al (2002) Association between adult-onset Still’s disease and interleukin-18 gene polymorphisms. Genes Immun 3:394–399CrossRefPubMed
11.
Zurück zum Zitat Maeno N, Takei S, Nomura Y, Imanaka H, Hokonohara M, Miyata K (2002) Highly elevated serum levels of interleukin-18 in systemic juvenile idiopathic arthritis but not in other juvenile idiopathic arthritis subtypes or in Kawasaki disease. Arthritis Rheum 46:2539–2541CrossRefPubMed Maeno N, Takei S, Nomura Y, Imanaka H, Hokonohara M, Miyata K (2002) Highly elevated serum levels of interleukin-18 in systemic juvenile idiopathic arthritis but not in other juvenile idiopathic arthritis subtypes or in Kawasaki disease. Arthritis Rheum 46:2539–2541CrossRefPubMed
12.
Zurück zum Zitat Sobieska M, Fassbender K, Aeschlimann A, Bourgeois P, Mackiewicz S, Muller W (1998) Still’s disease in children and adults: a distinct pattern of acute-phase proteins. Clin Rheumatol 17:258–260CrossRefPubMed Sobieska M, Fassbender K, Aeschlimann A, Bourgeois P, Mackiewicz S, Muller W (1998) Still’s disease in children and adults: a distinct pattern of acute-phase proteins. Clin Rheumatol 17:258–260CrossRefPubMed
13.
Zurück zum Zitat Cush JJ, Leibowitz IH, Friedman SA (1985) Adult-onset Still’s disease and inflammatory orbital pseudotumor. N Y State J Med 85:110–111PubMed Cush JJ, Leibowitz IH, Friedman SA (1985) Adult-onset Still’s disease and inflammatory orbital pseudotumor. N Y State J Med 85:110–111PubMed
14.
Zurück zum Zitat Mert A, Ozaras F, Tabak F, Bilir M, Ozturk R, Ozdogan H et al (2003) Fever of unknown origin: a review of 20 patients with adult-onset Still’s disease. Clin Rheumatol 22:89–93CrossRefPubMed Mert A, Ozaras F, Tabak F, Bilir M, Ozturk R, Ozdogan H et al (2003) Fever of unknown origin: a review of 20 patients with adult-onset Still’s disease. Clin Rheumatol 22:89–93CrossRefPubMed
15.
Zurück zum Zitat Husni ME, Maier AL, Mease PJ, Overman SS, Fraser P, Gravallese EM et al (2002) Etanercept in the treatment of adult patients with Still’s disease. Arthritis Rheum 46:1171–1176CrossRefPubMed Husni ME, Maier AL, Mease PJ, Overman SS, Fraser P, Gravallese EM et al (2002) Etanercept in the treatment of adult patients with Still’s disease. Arthritis Rheum 46:1171–1176CrossRefPubMed
16.
Zurück zum Zitat Vignes S, Wechsler B, Amoura Z, Papo T, Frances C, Huong DL et al (1998) Intravenous immunoglobulin in adult Still’s disease refractory to non-steroidal anti-inflammatory drugs. Clin Exp Rheumatol 16:295–298PubMed Vignes S, Wechsler B, Amoura Z, Papo T, Frances C, Huong DL et al (1998) Intravenous immunoglobulin in adult Still’s disease refractory to non-steroidal anti-inflammatory drugs. Clin Exp Rheumatol 16:295–298PubMed
17.
Zurück zum Zitat Cavagna L, Caporali R, Epis O, Bobbio-Pallavicini F, Montecucco C (2001) Infliximab in the treatment of adult Still’s disease refractory to conventional therapy. Clin Exp Rheumatol 19:329–332PubMed Cavagna L, Caporali R, Epis O, Bobbio-Pallavicini F, Montecucco C (2001) Infliximab in the treatment of adult Still’s disease refractory to conventional therapy. Clin Exp Rheumatol 19:329–332PubMed
18.
Zurück zum Zitat Pirildar T (2003) Treatment of adult-onset Still’s disease with leflunomide and chloroquine combination in two patients (letter). Clin Rheumatol 22:157CrossRefPubMed Pirildar T (2003) Treatment of adult-onset Still’s disease with leflunomide and chloroquine combination in two patients (letter). Clin Rheumatol 22:157CrossRefPubMed
19.
Zurück zum Zitat Quartier P, Taupin P, Bourdeaut F, Lemelle I, Pillet P, Bost M et al (2003) Efficacy of etanercept for the treatment of juvenile idiopathic arthritis according to the onset type. Arthritis Rheum 48:1093–1101CrossRefPubMed Quartier P, Taupin P, Bourdeaut F, Lemelle I, Pillet P, Bost M et al (2003) Efficacy of etanercept for the treatment of juvenile idiopathic arthritis according to the onset type. Arthritis Rheum 48:1093–1101CrossRefPubMed
20.
Zurück zum Zitat Minden K, Niewerth M, Listing J, Biedermann T, Bollow M, Schontube M et al (2002) Long-term outcome in patients with juvenile idiopathic arthritis. Arthritis Rheum 46:2392–2401CrossRefPubMed Minden K, Niewerth M, Listing J, Biedermann T, Bollow M, Schontube M et al (2002) Long-term outcome in patients with juvenile idiopathic arthritis. Arthritis Rheum 46:2392–2401CrossRefPubMed
21.
Zurück zum Zitat Besbas N, Saatci U, Bakkaloglu A, Ozen S (1992) Amyloidosis of juvenile chronic arthritis in Turkish children. Scand J Rheumatol 21:257–259PubMedCrossRef Besbas N, Saatci U, Bakkaloglu A, Ozen S (1992) Amyloidosis of juvenile chronic arthritis in Turkish children. Scand J Rheumatol 21:257–259PubMedCrossRef
Metadaten
Titel
A multicenter study of patients with adult-onset Still’s disease compared with systemic juvenile idiopathic arthritis
verfasst von
Salih Pay
Nuran Türkçapar
Mukaddes Kalyoncu
İsmail Şimşek
Esin Beyan
İhsan Ertenli
M. Akif Öztürk
Nurşen Düzgün
Hakan Erdem
Zeynep Özbalkan
Sedat Kiraz
Gülay Kınıklı
Nesrin Besbas
Ayhan Dinç
Aşkın Ateş
Ümit Ölmez
Meral Çalgüneri
Olcay Tiryaki Aydıntuğ
Ayşin Bakkaloğlu
Mustafa Turan
Murat Turgay
Yaşar Karaaslan
Rezzan Topaloğlu
Murat Duman
Seza Özen
Ankara Rheumatology Study Group
Publikationsdatum
01.09.2006
Verlag
Springer-Verlag
Erschienen in
Clinical Rheumatology / Ausgabe 5/2006
Print ISSN: 0770-3198
Elektronische ISSN: 1434-9949
DOI
https://doi.org/10.1007/s10067-005-0138-5

Weitere Artikel der Ausgabe 5/2006

Clinical Rheumatology 5/2006 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Erhebliches Risiko für Kehlkopfkrebs bei mäßiger Dysplasie

29.05.2024 Larynxkarzinom Nachrichten

Fast ein Viertel der Personen mit mäßig dysplastischen Stimmlippenläsionen entwickelt einen Kehlkopftumor. Solche Personen benötigen daher eine besonders enge ärztliche Überwachung.

Nach Herzinfarkt mit Typ-1-Diabetes schlechtere Karten als mit Typ 2?

29.05.2024 Herzinfarkt Nachrichten

Bei Menschen mit Typ-2-Diabetes sind die Chancen, einen Myokardinfarkt zu überleben, in den letzten 15 Jahren deutlich gestiegen – nicht jedoch bei Betroffenen mit Typ 1.

15% bedauern gewählte Blasenkrebs-Therapie

29.05.2024 Urothelkarzinom Nachrichten

Ob Patienten und Patientinnen mit neu diagnostiziertem Blasenkrebs ein Jahr später Bedauern über die Therapieentscheidung empfinden, wird einer Studie aus England zufolge von der Radikalität und dem Erfolg des Eingriffs beeinflusst.

Costims – das nächste heiße Ding in der Krebstherapie?

28.05.2024 Onkologische Immuntherapie Nachrichten

„Kalte“ Tumoren werden heiß – CD28-kostimulatorische Antikörper sollen dies ermöglichen. Am besten könnten diese in Kombination mit BiTEs und Checkpointhemmern wirken. Erste klinische Studien laufen bereits.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.